spacer
home > pmps > summer 2008 > taking the counterfeit risk out of traceability
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Taking the Counterfeit Risk Out of Traceability

A drug might go through up to 20 processes before it reaches patients. Since pharmaceutical supply chains are becoming longer, the risk of counterfeits making their way into the market is increasing. Pharmaceutical companies, associations and politicians are demanding track and trace devices for traceability and security against the counterfeiting of pharmaceuticals.

According to prognoses by WHO, the sales generated with counterfeit pharmaceuticals will reach $75 billion by 2010. This significant problem requires an urgent solution to ensure the safety of consumers. A combination of traceability and anti-fake marks could provide the answer.

According to the WHO, a counterfeit drug is a medicine that is deliberately and fraudulently mislabelled with respect to identity or source. A counterfeit might contain a wrong agent, or indeed no active agent at all. Counterfeiting, however, is not only limited to the drugs themselves – often the packaging of pharmaceuticals is also counterfeited.

Genuine pharmaceuticals can be wrongly packaged, so that for instance a patient buying heart pills might take a completely different drug without knowing. The fraud cannot be recognised at first (and sometimes not even at second) sight if the counterfeit drugs and the packaging are just too true to the original.

Besides enormous losses for the pharmaceutical industry, the immediate danger for consumers has become more prevalent. If fake drugs are circulated, this poses serious health risks for patients. In the past few years, the case of counterfeit anti-malarial drugs with the active agent Artesunat was published in the media and again made us aware of the danger of counterfeit drugs. The counterfeits contained either little or none of the Chinese herbs that are used to fight the most dangerous form of malaria.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Nicole Golomb is Marketing and Sales Manager for anti-counterfeit systems at 3S Simons Security Systems GmbH, Germany. She is in charge of the management of the specific customer projects dealing with individual applications of the micro colour-code system SECUTAG® on branded articles. Additionally, Nicole is responsible for the analysis of processing technologies in specific industries and the product protection system’s integration in the different sectors.
spacer
Nicole Golomb
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?

Clinical Professionals

Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement